AI transformation of Medical Affairs analytics

Challenge:
AstraZeneca was seeking to deepen and scale its use of artificial intelligence (AI) across R&D and operations, not as an experimental sidebar but as a strategic capability. Traditional workflows in drug discovery, trial design, and data integration were becoming bottlenecks. The challenge: embed AI into the organization in a way that leads to measurable impact — not just pilot projects, but sustainable systems, adoption, and ROI.

Solution:
ZONE3000 partnered with AstraZeneca to design and implement a strategic AI roadmap. The collaboration included identifying high-impact use cases, developing proof-of-concepts, and building scalable data and ML infrastructure. Governance frameworks and change-management programs ensured ethical and sustainable adoption.

Impact:

• Integrated AI into everyday research and decision-making

• Accelerated discovery cycles and improved trial predictions

• Established secure, compliant, and scalable AI systems

• Created a foundation for ongoing innovation across departments

Result:
AI moved from isolated experiments to a strategic capability driving measurable value across AstraZeneca’s global R&D ecosystem.